Share Name Share Symbol Market Type Share ISIN Share Description
Deltex Medical Group LSE:DEMG London Ordinary Share GB0059337583 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.125p -2.78% 4.375p 4.25p 4.50p 4.50p 4.375p 4.50p 174,091 08:17:45
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 6.4 -3.6 -1.6 - 12.47

Deltex Medical (DEMG) Latest News

More Deltex Medical News
Deltex Medical Takeover Rumours

Deltex Medical (DEMG) Share Charts

1 Year Deltex Medical Chart

1 Year Deltex Medical Chart

1 Month Deltex Medical Chart

1 Month Deltex Medical Chart

Intraday Deltex Medical Chart

Intraday Deltex Medical Chart

Deltex Medical (DEMG) Discussions and Chat

Deltex Medical Forums and Chat

Date Time Title Posts
21/10/201613:06Deltex Medical - a British success story!8,445
04/3/201612:50Deltex Medical - winner or doomed to fail? 148
14/7/201411:16Deltex Medical-Optimal Growth Stock10,005
22/3/201209:04Deltex Medical - Past, Present and Future-
07/12/201111:57Deltex Medical - More key endorsements-

Add a New Thread

Deltex Medical (DEMG) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Deltex Medical trades in real-time

Deltex Medical (DEMG) Top Chat Posts

Deltex Medical Daily Update: Deltex Medical Group is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker DEMG. The last closing price for Deltex Medical was 4.50p.
Deltex Medical Group has a 4 week average price of 4.98p and a 12 week average price of 5.26p.
The 1 year high share price is 6.25p while the 1 year low share price is currently 3.63p.
There are currently 284,935,182 shares in issue and the average daily traded volume is 521,478 shares. The market capitalisation of Deltex Medical Group is £12,465,914.21.
arf dysg: Any guesses as to why Lidco's share price and Deltex's share price have gone up today? I notice that Lidco, in its half-year report, says that it is the "clear market leader in the home market". Surely that wouldn't be a dig at anyone?
yump: I'm sure there's a lot of folk here who didn't realise that the share price had dropped from its peaks, so that's really helpful to know. Its just a shame that some super-clever folk couldn't have drawn in any lines down to 5p when the share price was 30p. Its probably worth posting on all the shares in the market with some lines showing what could happen on the downside. Then at least it will look like a prediction, rather than a statement of the bleeding obvious.
february 30th: Tbere isn't a correlation with Lidco. However both Deltex and Lidco have suffered from a declining UK market. The focus of shareholders is cashflow, but it is also the US market. Prior to 2012 the focus was the UK market - now the UK market is declining in importance. If the bulls are right, and the rate of US sales is increasing, and keeps increasing, then the dilutions should start drying up. Of course a take-over would be a better result for shareholders, because while the company is diluting, the share price is going to be stymied.
february 30th: If you look at the share prices of Deltex and Lidco from 2005 through to 2016, there is essentially no correlation: On the surface there does appear to be a small positive correlation, of 0.3. However when you strip out the impact of autocorrelation, the correlation disappears. So essentially they are unconnected. The correlation does change from year to year. The two years where you have had negative correlations, with one company's share price falling, and the other rising, are 2009 and 2016, to date: 2009 was when Lidco had its tie-up with Arrow, which arguably saved the company, even though the deal didn't give them a break-through in the US. This deal is used, e.g. by The Count, to demonstrate why partnerships would not necessarily be a good thing for Deltex. Looking at 2015 to 2016, we get the following: I suppose both Deltex and Lidco have been hit by reduced NHS spending, and the results of Lidco's disastrous Optimise trial have damaged both companies. I'm reminded of Boris the Dog's remark in "The Lady and the Tramp", in the dog pound: "Is like Gorky says in lower Dapts. Miserable being must find more miserable being. Then is happy". It seems likely that in the short-term both Deltex and Lidco will follow each other down, and I can't see good news from Lidco helping Deltex. Also, I think Deltex will continue falling without news, probably resting at 4p or lower by results. There is uneasiness about the cash situation, plus a worry that the US account targets may not be reached. Though hopefully there will be good news from the US soon, and the negative correlation in 2016 can be deepened.
february 30th: Well, it depends. It's a long time since I did a correlation between LID and DEMG, but overall it depends on what time period you are looking at. Long-term there is a positive correlation, in the sense that they are both going down. However there are periods of negative correlation. For example, 2009 was a great year for the LID share price, a terrible one for DEMG. Generally speaking, good news for Lidco will be bad for Deltex, good news for Deltex will be neutral for Lidco. And the ideal situation for Deltex is for Lidco to be in the middle of its price range, and the ideal situation for Lidco is for Deltex to be at the bottom of its range. However I'll try to redo the statistics, so I can give more support for my statements.
arf dysg: Hey, look! Our share price is sub 6p. Surely it has to go up from here?
doglover2003: When will DEMG overtake LID share price?
djgrantb: This share price defies logic, almost 190k bought and 48k sold, share price down, the MMs are having a laugh.... Strong buys the other day, the share price rises before any trades go through and doesn't move a jot all day....
buywell2: The DEMG share price is not funny or laughing matter for many I would hazard
doglover2003: -- > Feb 30th DEMG management would certainly defend the company very determinedly and would not be recommending any offer to shareholders unless of several multiples of turnover and payable 100 per cent in cash. Therefore, I think you would find that DEMG management would make the Optimise Trial a very important issue for LIDCO shareholders. Any offer by LIDCO would probably produce a re-rating of DEMG and a hammering for LIDCO share price which would make the whole takeover unworkable. Even today LIDCO failed to produce evidence in support of their technology without mentioning DEMG in the same breadth as part of the trial. As for the DEMG share price, the substantial fall in the share price took place on very modest volumes. Conversely, it would not take mega volume to move the price in the opposite direction. DL
Deltex Medical share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20161023 09:38:33